Literature DB >> 20414742

The involvement of PACAP/VIP system in the synaptic transmission in the hippocampus.

Kai Yang1, Gang Lei, Michael F Jackson, John F Macdonald.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are two closely related peptides, which can activate protein kinase A (PKA). At least three receptors for PACAP and VIP have been identified. The PACAP-specific receptor, PAC1 receptor, exhibits a higher affinity for PACAP than VIP, whereas VIP receptors, VPAC1-R and VPAC2-R, have similar affinities for PACAP and VIP. Both PACAP/VIP and their cognate receptors are highly expressed in the brain, including the hippocampus. Recently, their roles in the regulation of synaptic transmission have begun to emerge. PACAP/VIP can signal through different pathways to regulate N-methyl-D: -aspartate (NMDA) receptors in CA1 pyramidal cells. The activation of VPAC1/2-Rs increases evoked NMDA currents via the cyclic AMP/PKA pathway. However, the activation of PAC1-R stimulates a PLC/PKC/Pyk2/Src signaling pathway to enhance NMDA receptor function in hippocampal neurons. Furthermore, different concentrations of PACAP induce different effects on the both α-amino-3-hydroxy-5-isoxazole-propionic acid-evoked current and basal synaptic transmission by activating different receptors. Their roles in learning and memory are also demonstrated using transgenic mice and pharmacological methods.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414742     DOI: 10.1007/s12031-010-9372-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  59 in total

Review 1.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

2.  PACAP38 modulates activity of NMDA receptors in cultured chick cortical neurons.

Authors:  G J Liu; B W Madsen
Journal:  J Neurophysiol       Date:  1997-10       Impact factor: 2.714

3.  Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression.

Authors:  Wade Morishita; Wei Lu; Gordon B Smith; Roger A Nicoll; Mark F Bear; Robert C Malenka
Journal:  Neuropharmacology       Date:  2006-08-08       Impact factor: 5.250

4.  A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.

Authors:  Louise Dickson; Ichiro Aramori; James McCulloch; John Sharkey; Keith Finlayson
Journal:  Neuropharmacology       Date:  2006-08-23       Impact factor: 5.250

5.  VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.

Authors:  Diana Cunha-Reis; Joaquim Alexandre Ribeiro; Ana M Sebastião
Journal:  Brain Res       Date:  2005-07-05       Impact factor: 3.252

6.  Tonic adenosine A1 and A2A receptor activation is required for the excitatory action of VIP on synaptic transmission in the CA1 area of the hippocampus.

Authors:  D Cunha-Reis; B M Fontinha; J A Ribeiro; A M Sebastião
Journal:  Neuropharmacology       Date:  2006-10-09       Impact factor: 5.250

7.  Regulation of NMDA receptor Ca2+ signalling and synaptic plasticity.

Authors:  C Geoffrey Lau; Koichi Takeuchi; Alma Rodenas-Ruano; Yukihiro Takayasu; Jessica Murphy; Michael V L Bennett; R Suzanne Zukin
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

8.  Opposing effects by pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide on hippocampal synaptic transmission.

Authors:  Lucia Ciranna; Sebastiano Cavallaro
Journal:  Exp Neurol       Date:  2003-12       Impact factor: 5.330

9.  Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells.

Authors:  E Ciccarelli; M Svoboda; P De Neef; E Di Paolo; A Bollen; C Dubeaux; J P Vilardaga; M Waelbroeck; P Robberecht
Journal:  Eur J Pharmacol       Date:  1995-02-15       Impact factor: 4.432

10.  Regulation of glutamatergic signalling by PACAP in the mammalian suprachiasmatic nucleus.

Authors:  Stephan Michel; Jason Itri; Jung H Han; Kathryn Gniotczynski; Christopher S Colwell
Journal:  BMC Neurosci       Date:  2006-02-16       Impact factor: 3.288

View more
  22 in total

1.  Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression.

Authors:  Margarita Ivanova; Stiliana Belcheva; Iren Belcheva; Negrin Negrev; Roman Tashev
Journal:  Psychopharmacology (Berl)       Date:  2011-12-08       Impact factor: 4.530

2.  Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.

Authors:  Zhaoyang Xiao; Manoj K Jaiswal; Pan-Yue Deng; Toshimitsu Matsui; Hee-Sup Shin; James E Porter; Saobo Lei
Journal:  Hippocampus       Date:  2011-11-10       Impact factor: 3.899

3.  Genealogical correspondence of a forebrain centre implies an executive brain in the protostome-deuterostome bilaterian ancestor.

Authors:  Gabriella H Wolff; Nicholas J Strausfeld
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-01-05       Impact factor: 6.237

4.  Neuropeptide-mediated calcium signaling in the suprachiasmatic nucleus network.

Authors:  Robert P Irwin; Charles N Allen
Journal:  Eur J Neurosci       Date:  2010-10-12       Impact factor: 3.386

5.  Rapgef2 connects GPCR-mediated cAMP signals to ERK activation in neuronal and endocrine cells.

Authors:  Andrew C Emery; Maribeth V Eiden; Tomris Mustafa; Lee E Eiden
Journal:  Sci Signal       Date:  2013-06-25       Impact factor: 8.192

6.  Pituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuit.

Authors:  Jun-Hyeong Cho; Ko Zushida; Gleb P Shumyatsky; William A Carlezon; Edward G Meloni; Vadim Y Bolshakov
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

7.  VPAC1 and VPAC2 receptor activation on GABA release from hippocampal nerve terminals involve several different signalling pathways.

Authors:  Diana Cunha-Reis; Joaquim Alexandre Ribeiro; Rodrigo F M de Almeida; Ana M Sebastião
Journal:  Br J Pharmacol       Date:  2017-11-29       Impact factor: 8.739

8.  PACAP increases Arc/Arg 3.1 expression within the extended amygdala after fear conditioning in rats.

Authors:  Edward G Meloni; Karen T Kaye; Archana Venkataraman; William A Carlezon
Journal:  Neurobiol Learn Mem       Date:  2018-11-17       Impact factor: 2.877

9.  Bi-directional effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on fear-related behavior and c-Fos expression after fear conditioning in rats.

Authors:  Edward G Meloni; Archana Venkataraman; Rachel J Donahue; William A Carlezon
Journal:  Psychoneuroendocrinology       Date:  2015-11-07       Impact factor: 4.905

10.  PACAP receptor gene polymorphism impacts fear responses in the amygdala and hippocampus.

Authors:  Jennifer Strafford Stevens; Lynn M Almli; Negar Fani; David A Gutman; Bekh Bradley; Seth D Norrholm; Emily Reiser; Timothy D Ely; Rahim Dhanani; Ebony M Glover; Tanja Jovanovic; Kerry J Ressler
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.